About Robert Wah

Advocacy for Healthcare Policy Reform

Robert Wah has been a vocal critic of Medicare's Sustainable Growth Rate (SGR) formula, describing temporary fixes as creating 'nothing but trouble for physicians, patients and Congress' [2]. He expressed deep frustration with looming Medicare cuts, stating 'Disgruntled is probably just too soft of a term' [4]. Wah supported shifts in reimbursement from quantity to quality, aligning AMA commitments with HHS timelines [7], and raised concerns about the Meaningful Use program's pace amid flexibility rules [6].

Leadership in Major Health Organizations

As AMA President, Wah addressed national crises like Ebola alongside AHA leaders [3] and engaged on MACRA reforms, drawing parallels to med school rigor [5]. He served as CMO at Computer Sciences Corp (CSC) while practicing and teaching at Walter Reed [8]. Currently, he is Senior Advisor at Health2047 and involved with AMA Helping Innovation, focusing on health/biotech entrepreneurship [bio]. His health IT and military medicine background underscores expert leadership [10].

Reproductive Health and Fertility Expertise

A reproductive endocrinologist at NIH, Wah was highlighted at ASRM for fertility advancements [1]. He received the Endo Hero of the Year Award for supporting endometriosis patients as an original Worldwide EndoMarch Advisory Board member [9].

Health IT and Innovation

Wah advocated viewing MACRA like med school training [5] and worried about Meaningful Use's momentum [6]. His work promotes health engagement through IT [10].

Broader Impacts and Recognition

Wah's contributions span education, finance/investing, and entrepreneurship in health/biotech [bio].